In a regulatory filing last night, Madrigal Pharmaceuticals reported that Remy Sukhija, who has served as the company’s Chief Commercial Officer since April of 2020, is leaving the company to pursue other opportunities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MDGL:
- Madrigal Pharmaceuticals participates in a conf call hosted by Oppenheimer
- Goldman Sachs Says These 2 Stocks Could Double Your Money — Here’s Why They Could Jump
- Weight-loss drugs are bad news for medtech makers, Barron’s says
- Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Hold Rating Maintained for Madrigal Pharmaceuticals Amidst Leadership Change and Potential Market Catalysts